Yahoo Web Search

Search results

1. • 

     Sanofi's Dupixent gets U.S. approval to treat eczema in young children

     Reuters via Yahoo News· 2 years ago

     Dupixent is now the first approved treatment for moderate-to-severe eczema in young children, Sanofi...

2. • 

     Sanofi's (SNY) Dupixent Gets EU Nod for Eczema in Young Kids

     Zacks via Yahoo Finance· 1 year ago

     Sanofi (SNY) and Regeneron's Dupixent becomes the first and only targeted medicine approved to treat...

3. • 

     Danielle Jonas says her eczema affected her self-esteem and deterred her from going on tour often...

     INSIDER via Yahoo News· 8 months ago

     Danielle Jonas opened up about her eczema journey in a recent interview with Insider.Courtesy of...

4. • 

     Eczema and the COVID-19 Vaccine: Is it Safe?

     Verywell Health via Yahoo News· 1 year ago

     COVID-19 vaccines are safe for people who have eczema, an itchy rash that is the most common type of atopic dermatitis. The COVID-19 vaccines available...

5. • 

     ASLAN (ASLN) Up 161% on Upbeat Initial Data From Eczema Study

     Zacks via Yahoo Finance· 1 month ago

     ASLAN (ASLN) rises on upbeat initial data from a phase II study of eblasakimab in patients with...

6. • 

     Treatments for Eczema

     Health via Yahoo News· 5 months ago

     Eczema (also known as dermatitis) is a condition that primarily affects the skin, causing dryness, itchiness, scaliness, rashes, and blisters. In some...

7. • 

     Regeneron, Sanofi Plot A Major Expansion That Could Add $4 Billion In Future Sales

     Investor's Business Daily· 5 months ago

     Regeneron Pharmaceuticals and Sanofi said Monday their blockbuster drug, Dupixent, significantly...

8. • 

     How to manage eczema – according to a dermatologist

     The Telegraph via Yahoo News· 2 months ago

     The condition can be uncomfortable and create a sense of social embarrassment among sufferers For the one in 10 adults who will develop eczema at some...

9. • 

     Why Tech Leader Regeneron Shouldn't Sweat Its AbbVie Rival — For Now

     Investor's Business Daily· 2 years ago

     AbbVie could soon pressure Regeneron Pharmaceuticals in eczema treatment, an analyst said Friday as...

10. • 

      FDA puts hold on Rapt trials of drug for eczema, asthma

      BioPharma Dive via Yahoo Finance· 2 months ago

      Rapt reported one case of liver failure in a study participant who received the biotech’s drug,...